Alkermes, Inc. (ALKS) Reports In-Line Q4 Loss of 14c; Guides FY12
Alkermes, Inc. (NASDAQ: ALKS) reported Q4 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $42.28 million versus the consensus estimate of $46.32 million.
Sees FY12 loss of 38-47c, vs. the consensus of 30c loss. See sales of $205-$229 million, vs. the consensus of $213.7 million.
Sees FY12 loss of 38-47c, vs. the consensus of 30c loss. See sales of $205-$229 million, vs. the consensus of $213.7 million.